Skip to content
10-Q

Quarterly Report

CAPRICOR THERAPEUTICS, INC. CAPR

0001558370-25-007770

← back to feed
Filed
May 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 13, 2025 45.71M sh
Cash And Equivalents Q1 2025 · Mar 31, 2025 $28.79M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $11.29M
Current Liabilities Q1 2025 · Mar 31, 2025 $22.34M
Current Liabilities Q1 2025 · Dec 31, 2024 $21.03M
Total Liabilities Q1 2025 · Mar 31, 2025 $26.12M
Total Liabilities Q1 2025 · Dec 31, 2024 $25.02M
Current Assets Q1 2025 · Mar 31, 2025 $146.25M
Current Assets Q1 2025 · Dec 31, 2024 $163.39M
Total Assets Q1 2025 · Mar 31, 2025 $153.77M
Total Assets Q1 2025 · Dec 31, 2024 $170.48M
Shares Diluted Q1 2025 · Mar 31, 2024 31.35M sh
Capex Q1 2025 · Mar 31, 2024 $608.59K
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$1.27M
Stockholders Equity Q1 2025 · Mar 31, 2024 $18.43M
Stockholders Equity Q1 2025 · Dec 31, 2023 $22.6M
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.31
Eps Basic Q1 2025 · Mar 31, 2024 −$0.31
Sga Expense Q1 2025 · Mar 31, 2024 $4.07M
Rd Expense Q1 2025 · Mar 31, 2024 $11.1M
Net Income Q1 2025 · Mar 31, 2024 −$9.79M
Operating Income Q1 2025 · Mar 31, 2024 −$10.27M
Revenue Q1 2025 · Mar 31, 2024 $4.91M